105 related articles for article (PubMed ID: 11179665)
21. Distinct expression of C4.4A in colorectal cancer detected by different antibodies.
Yamamoto H; Oshiro R; Ohtsuka M; Uemura M; Haraguchi N; Nishimura J; Takemasa I; Mizushima T; Doki Y; Mori M
Int J Oncol; 2013 Jan; 42(1):197-201. PubMed ID: 23175173
[TBL] [Abstract][Full Text] [Related]
22. Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Magdelénat H; Vincent-Salomon A; Nos C; Boudou E; Pouillart P; Thiery JP; de Cremoux P
Int J Cancer; 2005 Mar; 114(2):291-8. PubMed ID: 15543615
[TBL] [Abstract][Full Text] [Related]
23. Expression of C4.4A in precursor lesions of pulmonary adenocarcinoma and squamous cell carcinoma.
Jacobsen B; Santoni-Rugiu E; Illemann M; Kriegbaum MC; Laerum OD; Ploug M
Int J Cancer; 2012 Jun; 130(11):2734-9. PubMed ID: 21792890
[TBL] [Abstract][Full Text] [Related]
24. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
26. [cDNA cloning and sequencing of human urokinase receptor].
Zhu FX; Jia SD; Gao LL; He FC
Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):461-3. PubMed ID: 11051819
[TBL] [Abstract][Full Text] [Related]
27. TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation.
Sang J; Lim YP; Panzica M; Finch P; Thompson NL
Cancer Res; 1995 Mar; 55(5):1152-9. PubMed ID: 7532544
[TBL] [Abstract][Full Text] [Related]
28. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
29. De novo synthesis of C4.4A in hepatocellular carcinoma promotes migration and invasion of tumor cells.
Görtz M; Galli U; Longerich T; Zöller M; Erb U; Schemmer P
Oncol Rep; 2017 Nov; 38(5):2697-2704. PubMed ID: 29048672
[TBL] [Abstract][Full Text] [Related]
30. Expression of C4.4A is a potential independent prognostic factor for patients with gastric cancer.
Cheng DQ; Gu XD; Li ZY; Xiang JB; Chen ZY
Asian Pac J Cancer Prev; 2014; 15(9):3895-9. PubMed ID: 24935570
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
Rofstad EK; Rasmussen H; Galappathi K; Mathiesen B; Nilsen K; Graff BA
Cancer Res; 2002 Mar; 62(6):1847-53. PubMed ID: 11912164
[TBL] [Abstract][Full Text] [Related]
32. Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy.
Claas C; Seiter S; Claas A; Savelyeva L; Schwab M; Zöller M
J Cell Biol; 1998 Apr; 141(1):267-80. PubMed ID: 9531564
[TBL] [Abstract][Full Text] [Related]
33. Coamplification in tumors of KRAS2, type 2 inositol 1,4,5 triphosphate receptor gene, and a novel human gene, KRAG.
Heighway J; Betticher DC; Hoban PR; Altermatt HJ; Cowen R
Genomics; 1996 Jul; 35(1):207-14. PubMed ID: 8661122
[TBL] [Abstract][Full Text] [Related]
34. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.
Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS
Oncology; 2004; 66(3):210-7. PubMed ID: 15218312
[TBL] [Abstract][Full Text] [Related]
35. C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M; Yamamoto H; Masuzawa T; Takahashi H; Uemura M; Haraguchi N; Nishimura J; Hata T; Yamasaki M; Miyata H; Takemasa I; Mizushima T; Takiguchi S; Doki Y; Mori M
Ann Surg Oncol; 2013 Aug; 20(8):2699-705. PubMed ID: 23435632
[TBL] [Abstract][Full Text] [Related]
36. Urokinase receptor antibody can reduce tumor volume and detect the presence of occult tumor metastases in vivo.
Rabbani SA; Gladu J
Cancer Res; 2002 Apr; 62(8):2390-7. PubMed ID: 11956102
[TBL] [Abstract][Full Text] [Related]
37. Expression of C4.4A in an In Vitro Human Tissue-Engineered Skin Model.
Jacobsen B; Larouche D; Rochette-Drouin O; Ploug M; Germain L
Biomed Res Int; 2017; 2017():2403072. PubMed ID: 29075641
[TBL] [Abstract][Full Text] [Related]
38. The urokinase receptor homolog Haldisin is a novel differentiation marker of stratum granulosum in squamous epithelia.
Gårdsvoll H; Kriegbaum MC; Hertz EP; Alpízar-Alpízar W; Ploug M
J Histochem Cytochem; 2013 Nov; 61(11):802-13. PubMed ID: 23896969
[TBL] [Abstract][Full Text] [Related]
39. Tetranectin, a plasminogen kringle 4-binding protein. Cloning and gene expression pattern in human colon cancer.
Wewer UM; Albrechtsen R
Lab Invest; 1992 Aug; 67(2):253-62. PubMed ID: 1354271
[TBL] [Abstract][Full Text] [Related]
40. [Mapping and expression analysis of a different expression cDNA fragment from lung adenocarcinoma cell line].
Fan H; Li Y; Feng HC; Lü BJ; Fu SB; Zhang GY; Li P
Yi Chuan Xue Bao; 2002 Jun; 29(6):476-80. PubMed ID: 12096622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
